SLEEP DISORDERED BREATHING, METABOLIC SYNDROME, AND VASCULAR FUNCTION
睡眠呼吸障碍、代谢综合征和血管功能
基本信息
- 批准号:7607517
- 负责人:
- 金额:$ 0.62万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-12-01 至 2007-09-16
- 项目状态:已结题
- 来源:
- 关键词:AreaAtherosclerosisBlood VesselsCohort StudiesComplexComputer Retrieval of Information on Scientific Projects DatabaseDiseaseFunctional disorderFundingGrantHeart RateHydrocortisoneHypercapniaHypoxemiaHypoxiaIncidenceIndividualInstitutionInsulin ResistanceInvasiveIsoprostanesLongitudinal StudiesMeasuresMetabolic syndromeNorepinephrineObesityOxidative StressParticipantRecruitment ActivityResearchResearch PersonnelResourcesRetinalRisk FactorsSamplingSleepSleep Apnea SyndromesSourceStressTestingUnited States National Institutes of HealthVascular Endothelial Growth FactorsVisitWisconsinbrachial arterycerebral arterycohorthypothalamic-pituitary-adrenal axismembermiddle ageurinaryvascular endothelial dysfunction
项目摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
[from CRISP website (edited)]
Insulin resistance and the metabolic syndrome share risk factors and disease-causing mechanisms with vascular endothelial dysfunction and atherosclerosis. Sleep disordered breathing (SDB) might be associated with this diesease-causing area in complex ways, both as a result (via obesity) and as a cause (via hypoxemia, oxidative stress, and sympathetic overload). The primary objective of this study is to study the longitudinal association between SDB and the incidence of the metabolic syndrome and vascular dysfunction in a sample of participants in the Wisconsin Sleep Cohort (WSC) Study (SPID 8813), a group of middle-age individuals who have undergone repeated full sleep studies over the last 15 years, up to four in each participants, four years apart.
A total of 600 participants with at least 2 visits in the WSC will be recruited into the study. This group includes a) about 150 cases of incident metabolic syndrome, and b) a random sample of about 450-470 members of the cohort. These participants will undergo non-invasive measures of vascular function including: (1) brachial artery reactivity; (2) cerebral artery responsiveness to hypercapnia; and (3) retinal arteriolar/venular ratio. In addition, we will measure markers of hypoxic stress (VEGF), oxidative stress (urinary isoprostane), and sympathetic and hypothalamic-pituitary-adrenal axis function (heart rate variability, urinary norepinephrine, urinary cortisol). The proposed study will test the hypothesis that recent or past SDB predicts incident metabolic syndrome and is related to the degree of insulin resistance (HOMA-IR), and vascular or endothelial dysfunction.
该子项目是利用该技术的众多研究子项目之一
资源由 NIH/NCRR 资助的中心拨款提供。子项目和
研究者 (PI) 可能已从 NIH 的另一个来源获得主要资金,
因此可以在其他 CRISP 条目中表示。列出的机构是
对于中心来说,它不一定是研究者的机构。
[来自 CRISP 网站(编辑)]
胰岛素抵抗和代谢综合征与血管内皮功能障碍和动脉粥样硬化有共同的危险因素和致病机制。睡眠呼吸障碍 (SDB) 可能以复杂的方式与这一致病区域相关,既可以作为结果(通过肥胖),也可以作为原因(通过低氧血症、氧化应激和交感神经超载)。本研究的主要目的是研究威斯康星州睡眠队列 (WSC) 研究 (SPID 8813) 参与者样本中 SDB 与代谢综合征和血管功能障碍发生率之间的纵向关联,该样本是一组在过去 15 年中重复进行完全睡眠研究的中年个体,每个参与者最多 4 人,间隔四年。
该研究将招募总共 600 名至少参加过 WSC 2 次的参与者。 该组包括 a) 约 150 例代谢综合征病例,以及 b) 约 450-470 名队列成员的随机样本。这些参与者将接受血管功能的非侵入性测量,包括:(1)肱动脉反应性; (2)脑动脉对高碳酸血症的反应性; (3)视网膜小动脉/小静脉比率。此外,我们还将测量缺氧应激 (VEGF)、氧化应激(尿异前列烷)以及交感神经和下丘脑-垂体-肾上腺轴功能(心率变异性、尿去甲肾上腺素、尿皮质醇)的标志物。拟议的研究将检验以下假设:最近或过去的 SDB 可以预测代谢综合征的发生,并且与胰岛素抵抗程度 (HOMA-IR) 以及血管或内皮功能障碍有关。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
F. JAVIER NIETO其他文献
F. JAVIER NIETO的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('F. JAVIER NIETO', 18)}}的其他基金
Novel population health approach to address CVD and pulmonary health disparities
解决心血管疾病和肺部健康差异的新型人口健康方法
- 批准号:
7854588 - 财政年份:2009
- 资助金额:
$ 0.62万 - 项目类别:
Novel population health approach to address CVD and pulmonary health disparities
解决心血管疾病和肺部健康差异的新型人口健康方法
- 批准号:
7941925 - 财政年份:2009
- 资助金额:
$ 0.62万 - 项目类别:
SLEEP DISORDERED BREATHING, METABOLIC SYNDROME, AND VASCULAR FUNCTION
睡眠呼吸障碍、代谢综合征和血管功能
- 批准号:
7204382 - 财政年份:2005
- 资助金额:
$ 0.62万 - 项目类别:
SLEEP DISORDERED BREATHING, METABOLIC SYNDROME, AND VASCULAR FUNCTION
睡眠呼吸障碍、代谢综合征和血管功能
- 批准号:
7375521 - 财政年份:2005
- 资助金额:
$ 0.62万 - 项目类别:
相似海外基金
Targeted ablation of cerebral atherosclerosis using supramolecular self-assembly
利用超分子自组装靶向消融脑动脉粥样硬化
- 批准号:
24K21101 - 财政年份:2024
- 资助金额:
$ 0.62万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
The Epigenetic Regulator Prdm16 Controls Smooth Muscle Phenotypic Modulation and Atherosclerosis Risk
表观遗传调节因子 Prdm16 控制平滑肌表型调节和动脉粥样硬化风险
- 批准号:
10537602 - 财政年份:2023
- 资助金额:
$ 0.62万 - 项目类别:
Targeted multimodal stimuli-responsive nanogels for atherosclerosis imaging and therapy
用于动脉粥样硬化成像和治疗的靶向多模式刺激响应纳米凝胶
- 批准号:
2880683 - 财政年份:2023
- 资助金额:
$ 0.62万 - 项目类别:
Studentship
Body composition and atherosclerosis-related biomarkers in women with endometriosis
子宫内膜异位症女性的身体成分和动脉粥样硬化相关生物标志物
- 批准号:
23K15842 - 财政年份:2023
- 资助金额:
$ 0.62万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Role of IL-6 trans signaling in atherosclerosis development and late-stage pathogenesis
IL-6反式信号传导在动脉粥样硬化发展和晚期发病机制中的作用
- 批准号:
10652788 - 财政年份:2023
- 资助金额:
$ 0.62万 - 项目类别:
From genotype to phenotype in a GWAS locus: the role of REST in atherosclerosis
GWAS 位点从基因型到表型:REST 在动脉粥样硬化中的作用
- 批准号:
10570469 - 财政年份:2023
- 资助金额:
$ 0.62万 - 项目类别:
Alcohol Regulation of Endothelial Plasticity in Atherosclerosis
酒精对动脉粥样硬化内皮可塑性的调节
- 批准号:
10585070 - 财政年份:2023
- 资助金额:
$ 0.62万 - 项目类别:
The role of extracellular vesicle-associated MicroRNAs in HIV-associated atherosclerosis
细胞外囊泡相关 MicroRNA 在 HIV 相关动脉粥样硬化中的作用
- 批准号:
10619831 - 财政年份:2023
- 资助金额:
$ 0.62万 - 项目类别:
MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS - TOPMED
动脉粥样硬化的多种族研究 - TOPMED
- 批准号:
10974007 - 财政年份:2023
- 资助金额:
$ 0.62万 - 项目类别:














{{item.name}}会员




